AlliendCorp_logo.png
Allied Corp Confirms No Material Undisclosed Information and Comments on Recent Promotional Activities
April 23, 2021 18:07 ET | Allied Corp.
KELOWNA, British Columbia, April 23, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health...
AlliendCorp_logo.png
Allied Corp. Announces Clearance From the Colombian Authorities to Export Cannabis Products Internationally
April 20, 2021 08:55 ET | Allied Corp.
KELOWNA, British Columbia, April 20, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health...
AlliendCorp_logo.png
Allied Corp Announces Production Results Showcasing Low Cost Per Gram, High Yield and Large Cannabinoid Percentages Positioning the Company for International Stage
April 15, 2021 08:55 ET | Allied Corp.
KELOWNA, British Columbia, April 15, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health...
AlliendCorp_logo.png
Allied Corp Secures US Footprint in Preparation for US Federal Legalization of Cannabis With Signing of Land Lease, Purchase of US License and Master Service Agreement
March 31, 2021 08:55 ET | Allied Corp.
KELOWNA, British Columbia, March 31, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is an international medical company focused on creating and providing health...
AlliendCorp_logo.png
Allied Corp Increases Intellectual Property Protection by Filing Trademark for Pharma Product PSILONEX
March 25, 2021 08:55 ET | Allied Corp.
KELOWNA, British Columbia, March 25, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health...
AlliendCorp_logo.png
Allied Files Provisional Patent for Psilocybin Therapeutic Invention Seeking Drug Indication for Mental Health Depression and Anxiety Applications
March 18, 2021 08:55 ET | Allied Corp.
KELOWNA, British Columbia, March 18, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied") (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted psilocybin...
AlliendCorp_logo.png
Allied Corp. Receives ICA Approval for Psychoactive THC Strains
March 09, 2021 08:55 ET | Allied Corp.
KELOWNA, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied") (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted psilocybin...
AlliendCorp_logo.png
Allied Corp. Launches Strategic North American Public Relations and Marketing Campaign
March 05, 2021 21:36 ET | Allied Corp.
KELOWNA, British Columbia, March 05, 2021 (GLOBE NEWSWIRE) -- Allied Corp. (the “Company” or “Allied”) (OTCQB: ALID) is pleased to announce that it has retained the services of IDR Marketing, Inc....
AlliendCorp_logo.png
Allied Corp Announces LOI to Purchase Nevada USA Cannabis License and Land Lease to Install the Allied US Facility
February 17, 2021 05:55 ET | Allied Corp.
KELOWNA, British Columbia, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied") (OTCQB: ALID) – an international medical company focused on creating and providing health solutions to address...
AlliendCorp_logo.png
Allied Completes Acquisition of Pacific Sun Fungi: A Leader in the Psilocybin Space
February 02, 2021 08:55 ET | Allied Corp.
KELOWNA, British Columbia, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied") (OTCQB: ALID) – an international medical company focused on creating and providing health solutions to address...